DelMar Pharmaceuticals, Inc. Employment Agreements
8 Contracts & Agreements
- Second Amended Employment Agreement, dated November 8, 2021, by and between the Company and Saiid Zarrabian (Filed With SEC on November 12, 2021)
- Executive Employment Agreement, dated November 8, 2021, by and between the Company and Robert Hoffman (Filed With SEC on November 12, 2021)
- First Amended Executive Employment Agreement, by and between Kintara Pharmaceuticals, Inc. and Saiid Zarrabian (Filed With SEC on November 12, 2020)
- Amendment No. 3 to Employment Agreement, dated as of April 6, 2020, by and between Adgero Biopharmaceuticals Holdings, Inc. and Steven J. Rychnovsky (Filed With SEC on June 16, 2020)
- Amendment No. 2 to Employment Agreement, dated as of April 6, 2018, by and between Adgero Biopharmaceuticals Holdings, Inc. and Steven J. Rychnovsky (Filed With SEC on June 16, 2020)
- Employment Agreement, dated as of April 8, 2016, by and between Adgero Biopharmaceuticals Holdings, Inc. and Steven J. Rychnovsky (Filed With SEC on June 16, 2020)
- Amended and Restated Employment Agreement, dated as of March 1, 2018, by and between Adgero Biopharmaceuticals Holdings, Inc. and John Liatos (Filed With SEC on June 16, 2020)
- Employment Agreement, dated May 21, 2018, by and between DelMar Pharmaceuticals, Inc. and Mr. Zarrabian (Filed With SEC on May 22, 2018)